Sr. Associate Director, Global R&D & Science Fellow
Bayer Healthcare LLC
Morristown, New Jersey
Debanjan (Deb) Das, is an innovation-driven technical manager with over 17 years of product development experience in driving projects from concept to commercialization. He has marketed more than 40 commercial products (small molecules & biologics), encompassing pre-clinical development, drug delivery strategies, scale-up expertise & proven leadership skills. His research interests encompass drug targeting to brain via oral & intranasal routes utilizing nano system-based delivery vehicles. In addition, he has worked extensively on novel brain-targeted nanoparticles, human blood brain barrier (BBB) cell line hCMEC/D3, bio adhesive microspheres, “needle-free” epidermal delivery of botulinum toxin (BOTOX®) via nano emulsions, delivery and gastro-retentive systems for delivery of small molecules & biologics. Currently, he serves as Sr. Associate Director and science fellow at Bayer Healthcare’s global R&D where he manages a team of scientists to bring “new-to-world” dosage forms by managing $1MM plus formulation development budget & Bayer’s global innovation pipeline of upwards of 200MM up to 1B €.
Disclosure information not submitted.
Advancing In Vitro Methods for Nose to Brain Delivery - Current Prospects and Future Possibilities
Monday, November 10, 2025
3:45 PM - 4:00 PM CT